Clover MS data Analysis software
BY CLINICIANS
Each feature included is the result of close interaction with experts to provide the most efficient and convenient workflow to answer bacterial analysis questions
FOR CLINICIANS
Strain typing, resistance identification and susceptibility testing research tools using MALDI-MS data. Access everywhere and share data with your team
AI powered
AI-powered algorithms, biomarker discovery, Machine Learning algorithms and your DA tools for MS data
About us
CLOVER Bioanalytical Software is a bioinformatics company specialized in data processing for Bioanalytical Chemistry and Microbial ID and other clinical diagnostics applications using mass spectrometry. Formed by a group of Ph.D. graduates with a wide expertise in business and research, it brings a perfect match to develop cutting-edge software and statistical analysis projects in the biomedical field.
We are specialized in mass spectrometry, its clinical applications and mass spectrometry imaging. But our expertise covers many more applications, like medical image processing, univariate and multivariate statistical analysis, and Big Data.
We are truly customer-oriented, keeping in mind the goals of our clients and the scalability of the systems. We count with experts in biomedicine, chemistry and biotechnology that speak your own language and understands your needs.
Specialist in Mass Spectrometry and Mass Spectrometry imaging
Our customer's purposes are also our own
We are Agile, Test-passionate and obsessed with clean, maintainable code
Strong world-wide partnerships, and willing to create much more
 |
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 868365 |
OUR TEAM
LUIS MANCERA, Ph.D.
Ismael Duque, Ph.D.
Jesús Jiménez, Ph.D.
Gema Méndez
Baltasar Ruiz
Manuel J. Arroyo
Advisory Board
Omar Belgacem, Ph.d.
Emmanuel Wey, M.D.
Gerald Stubiger, Ph.D.
Customers & Partners
Awards and recognitions
Best poster award in the 'Korean Academy of Marketing Science' Conference, August 2016
Granted with the 'ACTTiVAte' project given by Parque Tecnológico de la Salud of Granada, February 2017
First finalists of the 'AJE Granada' 2018 award in the category of entrepreneurial initiative, March 2018
Selected for the Minerva mentoring program, August 2018
Selected for the 2017 Torres Quevedo R&D state program, November 2018
Member of the winning team of the Oncothon event in the topic of cancer interception, November 2018
Awarded Seal of Excellence by the European Comission
Granted SME Instrument H2020 Phase 1 project by the European Comission, March 2019
Supported by
News
An improved MALDI-TOF MS data analysis pipeline for the identification of carbapenemase-producing Klebsiella pneumoniae
Authors: Eva Gato, Ignacio Pedro Constanso, Ana Candela, Fátima Galán, Bruno Kotska Rodiño-Janeiro, Manuel J. Arroyo, Gema Méndez, Luis Mancera, Tyler Alioto, Marta Gut, Ivo Gut, Miguel Álvarez-Tejado, Belén Rodríguez-Sánchez, Germán Bou, Marina Oviaño DOI: 10.1128/JCM.00800-21 We present the latest published paper at JCM as a result of our collaboration with Microbiology Service from Hospital Read more about An improved MALDI-TOF MS data analysis pipeline for the identification of carbapenemase-producing Klebsiella pneumoniae[…]
Implementation of MALDI-TOF Mass Spectrometry and Peak Analysis: Application to the Discrimination of Cryptococcus neoformans Species Complex and their Interspecies Hybrids
Author: Manuel J. Arroyo Pulgar Abstract: Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) has been widely implemented for the rapid identification of microorganisms. Although most bacteria, yeasts and filamentous fungi can be accurately identified with this method, some closely related species still represent a challenge for MALDI-TOF MS. In this study, two MALDI-TOF based Read more about Implementation of MALDI-TOF Mass Spectrometry and Peak Analysis: Application to the Discrimination of Cryptococcus neoformans Species Complex and their Interspecies Hybrids[…]
Initiatives to fight against antimicrobial resistance
Author: Verónica Sánchez Mercado As we know, antibiotics are medicines used to prevent and treat bacterial infections in humans and animals and resistance mechanisms occur when bacteria change in response to the use of these medicines. Antimicrobial resistance (AMR) is one of the biggest threats to global health. Nowadays, a growing number of infections are Read more about Initiatives to fight against antimicrobial resistance[…]
MALDI-TOF MS: A technology beyond bacterial analysis and biotyping
Author: Manuel J. Arroyo Pulgar At Clover Biosoft, we develop methods to identify and classify resistant microorganisms reducing time to result and cost of other methods and reagents. But our technology can go much beyond that. One of the advantages of mass spectrometry technology is its versatility, which can be used in many research fields, Read more about MALDI-TOF MS: A technology beyond bacterial analysis and biotyping[…]
New machine learning model leads to the discovery of powerful antibiotics
Author: Manuel J. Arroyo Pulgar Using a machine-learning algorithm, MIT researchers have identified a powerful new antibiotic compound. In laboratory preliminary test, the drug killed many of the world’s most problematic disease-causing bacteria, including Acinetobacter baumannii and Enterobacteriaceae. To understand the relevance of such discovery, these bacteria are two of three high-priority pathogens that the Read more about New machine learning model leads to the discovery of powerful antibiotics[…]
Clover Biosoft accesses tailor-made business opportunities with AB InBev
Author: Manuel J. Arroyo Pulgar On 19-20 February 2020, companies supported under the European Innovation Council (EIC) had the opportunity to accelerate their business collaborating with AB InBev, the world’s leading brewer and one of Europe’s biggest food and drinks companies. AB InBev opened its doors to 32 SMEs to pitch and present their business Read more about Clover Biosoft accesses tailor-made business opportunities with AB InBev[…]
The ESKAPE bacteria group and its clinical importance
Author: Manuel J. Arroyo Pulgar Health care-associated infections (HAIs) occur when receiving health care for another condition [1]. These infections can happen in any health-care facility and can be caused by any pathogen. A bigger problem in these HAIs is when the pathogen that caused the infection has an antibiotic resistance, something we talked about Read more about The ESKAPE bacteria group and its clinical importance[…]
Alarming news in CDC’s 2019 Antibiotic Resistance Threats Report
Author: Manuel J. Arroyo Pulgar Centers for Disease Control and Prevention (CDC) just released the 2019 Antibiotic Resistance Threats Report in the United States. It includes statistics about infection due to resistant microorganisms in the U.S., an updated threats list about new antibiotic resistances and a lot of interesting complementary information about this worldwide problem, Read more about Alarming news in CDC’s 2019 Antibiotic Resistance Threats Report[…]
Health alert in Spain issued by Listeria monocytogenes
Authors: Manuel J. Arroyo Pulgar, Verónica Sánchez Mercado Listeriosis is an infection caused by a pathogenic bacterium called Listeria monocytogenes. Is one of the most virulent foodborne pathogens and in hight-risk individuals like pregnant women, older adults and people whose immune systems are compromised. In these population, the infection can be mortal and, in the Read more about Health alert in Spain issued by Listeria monocytogenes[…]
Using of MALDI-TOF in hospitals
Authors: Buyun Qi, Alfonso García Naranjo, Manuel J. Arroyo Pulgar In our first post ‘World alert: Antimicrobial resistance‘ we discussed about the problem of antimicrobial resistance and the difficulty of fighting these infections, as well as the laborious and time-consuming current methods to identify these microorganisms. On the other hand, MALDI-TOF MS is a recent Read more about Using of MALDI-TOF in hospitals[…]
EN 
ES